Vimarsana
Biggest News Aggregation in the World

New Cause News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from New Cause. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In New Cause Today - Breaking & Trending Today

Ponzi Perspectives: 2023 Midyear Roundup | McGuireWoods LLP - Vimarsana News

Ponzi Perspectives: 2023 Midyear Roundup | McGuireWoods LLP

Since 2021, McGuireWoods’ Ponzi Litigation team has been tracking and posting case alerts on Ponzi-related complaints filed in federal and state courts throughout the country and...

Preschool Puts Children in Blackface to Celebrate Black History Month – PJ Media - Vimarsana News

Preschool Puts Children in Blackface to Celebrate Black History Month – PJ Media

The preschool's messaging app featured a picture of children painted in blackface. The photo was captioned, “Black History Month.”

Non-Compete News: The End Of New Jersey Non-Competes As We Know Them? - Contract of Employment - Vimarsana News

Non-Compete News: The End Of New Jersey Non-Competes As We Know Them? - Contract of Employment

Last week, the New Jersey Assembly's Labor Committee passed bill A3715, designed to sharply limit the available provisions, use, and enforceability of restrictive covenants in employment contracts by New Jersey employers.

Source: mondaq.com
Frontiers | Case Report: Delayed Onset Multi-Organ Toxicities in a Melanoma Patient Achieving Complete Response to BRAF/MEK Inhibition - Vimarsana News

Frontiers | Case Report: Delayed Onset Multi-Organ Toxicities in a Melanoma Patient Achieving Complete Response to BRAF/MEK Inhibition

Autoimmune toxicities, while common following treatment with cancer immunotherapies, are not well-characterized in patients treated with BRAF/MEK inhibitors. Emerging data suggest that autoimmune effects may be linked with superior responses to both treatment modalities; however, there is little evidence describing mechanisms of immune-related toxicity for patients on BRAF/MEK inhibitors. Here we describe the experience of a 59-year-old HLA-A2, A29, B27-positive male patient with recurrent/metastatic melanoma. After progression on checkpoint inhibitor therapy, he was treated with dabrafenib/tr...

Frontiers | Evaluating Greenhouse Gas Emissions and Climate Mitigation Goals of the Global Food and Beverage Sector - Vimarsana News

Frontiers | Evaluating Greenhouse Gas Emissions and Climate Mitigation Goals of the Global Food and Beverage Sector

The dramatic increase of emitted greenhouse gases (GHGs) by humans over the past century and a half has created an urgency for monitoring, reporting, and verifying GHG emissions as a first step towards mitigating the effects of climate change. Fifteen percent of global GHG emissions come from agriculture, and companies in the food and beverage industry are starting to set climate goals. We examined the GHG emissions reporting practices and climate goals of the top 100 global food and beverage companies and determined whether their goals are aligned with the science of keeping climate warming w...